Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Aerosol: SOP for Conducting Forced Degradation Studies on Aerosols – V 2.0

Posted on By

Aerosol: SOP for Conducting Forced Degradation Studies on Aerosols – V 2.0

Procedure for Conducting Forced Degradation Studies on Aerosol Products

Department Aerosol
SOP No. SOP/Aerosol/197/2025
Supersedes SOP/Aerosol/197/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the methodology for conducting forced degradation studies on aerosol products to assess their stability, degradation pathways, and potential impact on product quality.

2. Scope

This SOP applies to all aerosol formulations subjected to forced degradation conditions, including oxidative, thermal, photolytic, and hydrolytic stress conditions.

3. Responsibilities

  • Quality Control (QC) Analysts: Responsible for conducting degradation studies.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving test results.
  • Stability Study Team: Responsible for sample selection and monitoring degradation trends.
  • Regulatory Affairs Team: Responsible for ensuring compliance with ICH stability guidelines.
See also  Aerosol: SOP for Preventing Mix-Ups During Material Handling - V 2.0

4. Accountability

The Quality Control Manager is accountable for ensuring accurate degradation studies and compliance with regulatory standards.

5. Procedure

5.1. Selection of Test Samples

  1. Select representative aerosol product samples for testing.
  2. Ensure each sample is appropriately labeled and stored.
  3. Record sample details in the Forced Degradation Sample Log (Annexure-1).

5.2. Forced Degradation Conditions

  1. Apply different stress conditions:
    • Oxidative stress (H₂O₂ exposure at 3% concentration).
    • Thermal stress (60°C for 10 days).
    • Photolytic stress (UV exposure for 24 hours).
    • Hydrolytic stress (moisture exposure at 75% RH).
  2. Record degradation study conditions in the Degradation Study Log
(Annexure-2).

5.3. Analytical Testing of Degraded Samples

  1. Analyze samples using HPLC, GC-MS, or spectrophotometric methods.
  2. Compare degraded samples with control samples.
  3. Document analytical results in the Degradation Analysis Report (Annexure-3).

5.4. Identification of Degradation Products

  1. Identify potential degradation by-products.
  2. Assess the toxicity and impact of degradation products on product efficacy.
  3. Record findings in the Degradation Product Identification Log (Annexure-4).

5.5. Risk Assessment and Corrective Actions

  1. Evaluate whether degradation impacts product quality.
  2. Determine if formulation modifications are required.
  3. Document corrective actions in the Degradation Study Corrective Action Log (Annexure-5).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • HPLC: High-Performance Liquid Chromatography
  • GC-MS: Gas Chromatography-Mass Spectrometry
  • RH: Relative Humidity
  • ICH: International Council for Harmonisation

7. Documents

  1. Forced Degradation Sample Log (Annexure-1)
  2. Degradation Study Log (Annexure-2)
  3. Degradation Analysis Report (Annexure-3)
  4. Degradation Product Identification Log (Annexure-4)
  5. Degradation Study Corrective Action Log (Annexure-5)

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • ICH Q1A and Q1B Stability Guidelines
  • FDA Guidelines on Forced Degradation Studies

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Forced Degradation Sample Log

Batch No. Sample ID Stress Condition Checked By
BN-250 SPL-401 60°C for 10 Days QA Team

Annexure-2: Degradation Study Log

Sample ID Degradation Type Observation Period Reviewed By
SPL-401 Oxidation 10 Days QA Team

Annexure-3: Degradation Analysis Report

Batch No. Analysis Method Degradation % Reviewed By
BN-251 HPLC 5.2% QA Team

Annexure-4: Degradation Product Identification Log

Degradation Product Toxicity Risk Regulatory Limit Reviewed By
Impurity X Low Below Limit QA Team

Annexure-5: Degradation Study Corrective Action Log

Issue Identified Corrective Action Implementation Date Approved By
Degradation Above Limit Formulation Change 08/02/2025 Anjali Sharma

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
01/01/2025 V 2.0 Updated degradation study parameters GMP Compliance Anjali Sharma
See also  Aerosol: SOP for Updating Validation Master Plans for Aerosol Manufacturing - V 2.0
Aerosols V 2.0 Tags:Aerosol Batch Production, Aerosol Can Design, Aerosol Cold Filling, Aerosol Documentation Standards, Aerosol Emissions Control, Aerosol Environmental Regulations, Aerosol equipment calibration, Aerosol Filling Process, Aerosol Fire Safety Measures, Aerosol Formulation, Aerosol Good Manufacturing Practice (GMP), Aerosol Hazardous Materials Handling, Aerosol Incident Reporting, Aerosol Leak Testing, Aerosol Maintenance Schedules, Aerosol Personal Protective Equipment (PPE), Aerosol Pressure Filling, Aerosol Product Labeling, Aerosol Product Testing, Aerosol Propellant Selection, Aerosol quality control, Aerosol Regulatory Compliance, Aerosol Risk Assessment, Aerosol Safety Protocols, Aerosol Standard Operating Procedures (SOPs), Aerosol Storage Requirements, Aerosol Training Programs, Aerosol Valve Crimping, Aerosol Ventilation Systems, Aerosol Waste Disposal

Post navigation

Previous Post: Analytical Method Development: SOP for Accuracy and Recovery Studies – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Evaluating Injection Viscosity and Compatibility – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version